List of Tables
Table 1. Global ALK Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global ALK Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global ALK Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global ALK Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global ALK Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global ALK Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global ALK Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market ALK Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of ALK Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of ALK Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of ALK Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of ALK Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ALK Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on ALK Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ALK Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global ALK Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global ALK Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global ALK Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global ALK Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global ALK Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global ALK Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global ALK Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global ALK Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America ALK Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America ALK Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America ALK Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America ALK Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America ALK Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe ALK Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe ALK Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe ALK Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe ALK Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe ALK Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific ALK Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific ALK Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific ALK Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific ALK Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific ALK Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America ALK Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America ALK Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America ALK Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America ALK Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America ALK Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa ALK Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa ALK Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa ALK Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa ALK Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa ALK Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global ALK Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global ALK Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global ALK Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global ALK Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global ALK Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global ALK Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global ALK Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global ALK Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global ALK Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global ALK Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global ALK Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global ALK Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global ALK Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global ALK Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global ALK Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global ALK Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global ALK Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global ALK Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global ALK Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global ALK Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer ALK Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis ALK Inhibitors Product
Table 79. Novartis Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Roche ALK Inhibitors Product
Table 84. Roche Recent Developments/Updates
Table 85. Takeda Pharmaceuticals Company Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Takeda Pharmaceuticals ALK Inhibitors Product
Table 89. Takeda Pharmaceuticals Recent Developments/Updates
Table 90. Betta Pharmaceuticals Company Information
Table 91. Betta Pharmaceuticals Description and Business Overview
Table 92. Betta Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Betta Pharmaceuticals ALK Inhibitors Product
Table 94. Betta Pharmaceuticals Recent Developments/Updates
Table 95. Qilu Pharmaceutical Company Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Qilu Pharmaceutical ALK Inhibitors Product
Table 99. Qilu Pharmaceutical Recent Developments/Updates
Table 100. Wanbang Biopharmaceuticals Company Information
Table 101. Wanbang Biopharmaceuticals Description and Business Overview
Table 102. Wanbang Biopharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Wanbang Biopharmaceuticals ALK Inhibitors Product
Table 104. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 105. Jiangsu Aosaikang Pharmaceutical Company Information
Table 106. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 107. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product
Table 109. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 110. Natco Pharma Company Information
Table 111. Natco Pharma Description and Business Overview
Table 112. Natco Pharma ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Natco Pharma ALK Inhibitors Product
Table 114. Natco Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. ALK Inhibitors Distributors List
Table 118. ALK Inhibitors Customers List
Table 119. ALK Inhibitors Market Trends
Table 120. ALK Inhibitors Market Drivers
Table 121. ALK Inhibitors Market Challenges
Table 122. ALK Inhibitors Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of ALK Inhibitors
Figure 2. Global ALK Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global ALK Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Crizotinib Product Picture
Figure 5. Ceritinib Product Picture
Figure 6. Ensartinib Product Picture
Figure 7. Alectinib Product Picture
Figure 8. Brigatinib Product Picture
Figure 9. Lorlatinib Product Picture
Figure 10. Iruplinalkib Product Picture
Figure 11. Other Product Picture
Figure 12. Global ALK Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 13. Global ALK Inhibitors Market Share by Application: 2025 & 2032
Figure 14. Hospital and Clinic
Figure 15. Retail Pharmacies
Figure 16. Other
Figure 17. Global ALK Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global ALK Inhibitors Market Size (US$ Million), 2021–2032
Figure 19. Global ALK Inhibitors Sales (K Units), 2021–2032
Figure 20. Global ALK Inhibitors Average Price (US$/Unit), 2021–2032
Figure 21. ALK Inhibitors Report Years Considered
Figure 22. ALK Inhibitors Sales Share by Manufacturers in 2025
Figure 23. Global ALK Inhibitors Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global ALK Inhibitors Players: Market Share by Revenue in ALK Inhibitors in 2025
Figure 25. ALK Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global ALK Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America ALK Inhibitors Sales Market Share by Country (2021–2032)
Figure 28. North America ALK Inhibitors Revenue Market Share by Country (2021–2032)
Figure 29. United States ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe ALK Inhibitors Sales Market Share by Country (2021–2032)
Figure 32. Europe ALK Inhibitors Revenue Market Share by Country (2021–2032)
Figure 33. Germany ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific ALK Inhibitors Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific ALK Inhibitors Revenue Market Share by Region (2021–2032)
Figure 40. China ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America ALK Inhibitors Sales Market Share by Country (2021–2032)
Figure 48. Latin America ALK Inhibitors Revenue Market Share by Country (2021–2032)
Figure 49. Mexico ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa ALK Inhibitors Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa ALK Inhibitors Revenue Market Share by Country (2021–2032)
Figure 55. Turkey ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE ALK Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of ALK Inhibitors by Type (2021–2032)
Figure 59. Global Revenue Market Share of ALK Inhibitors by Type (2021–2032)
Figure 60. Global ALK Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of ALK Inhibitors by Application (2021–2032)
Figure 62. Global Revenue Market Share of ALK Inhibitors by Application (2021–2032)
Figure 63. Global ALK Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 64. ALK Inhibitors Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
